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Summary
Dementia is the cardinal feature of Alzheimer’s disease (AD), yet
the clinical symptoms of this disorder also include a marked loss
of motor function. Tau abnormal hyperphosphorylation and
malfunction are well-established key events in AD neuropathol-
ogy but the impact of the loss of normal Tau function in neuronal
degeneration and subsequent behavioral deficits is still debated.
While Tau reduction has been increasingly suggested as thera-
peutic strategy against neurodegeneration, particularly in AD,
there is controversial evidence about whether loss of Tau
progressively impacts on motor function arguing about damage
of CNS motor components. Using a variety of motor-related tests,
we herein provide evidence of an age-dependent motor impair-
ment in Tau/ animals that is accompanied by ultrastructural
and functional impairments of the efferent fibers that convey
motor-related information. Specifically, we show that the sciatic
nerve of old (17–22-months) Tau/ mice displays increased
degenerating myelinated fibers and diminished conduction prop-
erties, as compared to age-matched wild-type (Tau+/+) litter-
mates and younger (4–6 months) Tau/ and Tau+/+ mice. In
addition, the sciatic nerves of Tau/ mice exhibit a progressive
hypomyelination (assessed by g-ratio) specifically affecting large-
diameter, motor-related axons in old animals. These findings
suggest that loss of Tau protein may progressively impact on
peripheral motor system.
Key words: Tau; motor deficits; peripheral nerve; myelination;
nerve conduction; knockout.
Introduction
Clinical presentation of Alzheimer’s disease (AD) is complex and extends
well beyond the cognitive impairments that characterize this disorder
(Duker et al., 2012). Alterations in facial expression, gait and posture, and
manifestations of rigidity, bradykinesia, and tremor are found in late AD
stages althoughmountingevidence suggests thatmotor problemsemerge
long before any recognizable sign of AD (Wilson et al., 2000; Scarmeas
et al., 2004; Buchman & Bennett, 2011). Tau abnormal hyperphospho-
rylation and subsequentmalfunction are postulated as crucialmechanisms
in AD neuronal dysfunction where hyperphosphorylated and/or aggre-
gated (insoluble) forms of Tau exhibit neurodegenerative action(s) that
also interfere with normal Tau, sequestering and reducing soluble Tau
forms (Ksiezak-Reding et al., 1988; Zhukareva et al., 2003). These lesions
aremainly foundat different areas ofCNS such ashippocampusand cortex
although some studies also demonstrate the presence of Tau deficits in
peripheral nervous system (PNS; e.g., autonomic ganglia and sciatic nerves
Bohl et al., 1997; Holzer et al., 1999). While evidence suggests that Tau
reduction can block AD pathology progression (Roberson et al., 2007),
indicating that Tau-targeted strategies might be of interest for AD therapy
(Gotz et al., 2012), the safety and/or potential side effect(s) of these
approaches is not well studied.
Tau genetic deletion seems to be well tolerated by young animals as
the majority of Tau/ models do not exhibit behavioral or microtubule
alterations (Dawson et al., 2001; reviewed by Ke et al., 2012). However,
chronic loss of Tau has been described to result in subtle or mild motor
deficits in increasingly aged animals (reviewed by Gotz et al., 2013).
Indeed, one study revealed loss of substantia nigra (SN) dopaminergic
neurons in middle-aged Tau/ animals (Lei et al., 2012), while in
another study, using aged Tau/ of the same strain, similar motor
deficits were shown but in a SN-/dopamine-independent manner (Morris
et al., 2013), raising uncertainty on the underlying mechanisms of the
motor deficits in Tau/ animals. Surprisingly, the involvement of the
PNS has not been assessed in any of the previous studies given the fact
that Tau reduction is found in peripheral nerves (e.g., sciatic nerve) of
patients with AD (Holzer et al., 1999). This study aimed therefore to
monitor the impact of chronic loss of Tau protein in PNS efferents,
primary compartment of motor circuitry, and motor performance using a
battery of behavioral tests analyzing motor function in both young (4–
6 months) and old (17–22 months) Tau/ mice combined with a
systematic morphofunctional analysis of their sciatic nerve.
Results
Chronic lack of Tau results in motor deficits in old animals
To clarify the discrepancies of previous studies regarding the age-
dependent motor deficits in Tau/ animals (cf. Lei et al., 2012 and
Morris et al., 2013), we performed a battery of motor-related behavioral
tests in adult (4–6 months old) and old (17–22 months old) male Tau/
and Tau+/+ animals. Motor function/coordination and locomotor activity
were assessed in the rotarod and open-field tests, respectively. As shown
in Fig. 1A, the accelerating protocol of rotarod test showed that old
Tau/ animals presented reduced latency to fall, indicating an impair-
ment in motor coordination. Two-way ANOVA rendered an overall
genotype effect [F1,37 = 4.050, p = 0.021], where old Tau/ exhibit a
motor impairment when compared with old Tau+/+ (p = 0.019). In the
open-field arena, we found a Genotype x Aging interaction of total area
travelled by the animals [F1,31 = 4.339, p = 0.045] (Fig. 1B). Further
analysis revealed that old Tau/ travelled significantly less than their
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age-matched Tau+/+ (p = 0.005) as well as than adult Tau/ animals
(p = 0.019). As potential body weight differences among groups could
affect the assessment of the abovemotor-related parameters, wemonitor
body weight of these animals (adult Tau+/+: 27.876  0.95; adult
Tau/: 27.879  0.53; old Tau+/+: 34.943  0.60; old Tau/:
36.215  1.67) finding no overall Genotype ([F1,37 = 0.4187,
p = 0.52]), but a significant Aging overall effect ([F1,37 = 61.15,
p < 0.0001]). Further analysis showed that both old Tau+/+ and
Tau/ animals exhibit higher body weight than their younger counter-
parts (p < 0.0001 for both genotypes). For monitoring muscle strength,
we use wire-hanging test where a Genotype x Aging interaction
[F1,31 = 5.768, p = 0.022] was found; old Tau/ present significantly
less hanging time than old Tau+/+ (P = 0.008) as well as when compared
with adult Tau/ (p = 0.0001) suggesting compromised muscle
strength (Fig. 1C). Furthermore, monitoring separately hindlimb and
forelimb performance by hindlimb tonus and forelimb grid strength tests,
we found a Genotype x Aging interaction (for tonus F1,38 = 11.97,
p = 0.001; for strength F1,38 = 12.14, p = 0.001) represented by dimin-
ished hindlimb tonus resistance and reduced forelimb strength in old
Tau/ animals when compared to old Tau+/+ (ptonus = 0.0003 and
pstrength = 0.004, respectively; Fig. 1D,E); note that this difference was
not found in adult animals (ptonus = 0.98 and pstrength = 0.80, respec-
tively) in line with the findings of the above tests used in this study. In
addition, no significant changes among groups were found in hindlimb
clasping score (Fig. 1F). Moreover, for extra monitoring of motor
coordination and gait, we performed footprinting-based analysis showing
a Genotype x Aging interaction in the stride length of animals
(F1,23 = 4.69, p = 0.04) where, in contrast to adult animals, old Tau/
presented a decreased stride length when compared to old Tau+/+
(p = 0.03) (Fig. 1G). In addition, we found an Aging main effect on
forepaw base (F1,23 = 13.01, p = 0.001) where old Tau/ animals
presented an increase in this parameter compared to adult Tau/
animals (p = 0.04) (Fig. 1H). No significant differences were found in
other parameters of gait analysis such as hindpaw base and forepaw–
hindpaw overlap.
Tau ablation alters sciatic nerve structure and function by
aging
As Tau/ mice are shown to exhibit motor deficits, it was of interest to
monitor the impact of Tau ablation on the peripheral component of
motor circuit; for that purpose, we studied the sciatic nerve, in the same
mouse line and background (C57BL/6; Dawson et al., 2001) used in
previous studies describing motor deficits after Tau ablation (Morris
et al., 2013; Lei et al., 2014). It is important to note that the sciatic nerve
is known to exhibit important morphological and functional changes
with aging (Melcangi et al., 2000). Thus, we monitored myelinated
(A-fibers) density in p-phenylene diamine (PPD)-stained sections. In
agreement with previous studies (Ceballos et al., 1999), two-way
ANOVA showed an aging effect [F1,16 = 11.71, p = 0.0038] with aged
animals exhibiting reduced density of myelinated fibers independently of
genotype (p < 0.05 for both genotypes) (Fig. 2A,B). Furthermore,
electron micrographs of the sciatic nerves revealed, in addition to
normal myelinated axons (Fig. 2Ci), the presence of dysmorphic myelin
sheaths as shown in Fig. 2Cii–iv. Thus, we also evaluated the percentage
of myelinated fibers that exhibit the above abnormalities in their myelin
sheath finding an overall aging effect [F1,16 = 7.41, p = 0.015] and an
overall genotype effect [F1,16 = 5.58, p = 0.031]. Additional analysis
showed a significant increase in the percentage of degenerating
myelinated fibers in old Tau/ animals when compared with old
Tau+/+ animals (p = 0.049) and adult Tau/ (p = 0.0289) (Fig. 2D). In
the next step of our analysis, we compared myelin sheath thickness of
fibers of sciatic nerves by electron microscopy determining the g-ratio,
an index of myelination independent of axonal diameter (Michailov
et al., 2004). A total of 2885 axons were sampled and classified
according to axon diameter. Tau/ axons exhibited increased g-ratio
indicating reduced myelination while two-way ANOVA per category
exhibited an overall Genotype effect in all categories [F1,270 = 23.891,
p < 0.001 (0–2 lm); F1,1390 = 99.885, p < 0.001 (2–4 lm);
F1,705 = 132.891, p < 0.001 (4–6 lm); F1,372 = 39.379, p < 0.001 (6–
8 lm); F1,143 = 9.060, p = 0.02 (8–10 lm)] and an age effect
[F1,1390 = 31.672 (2–4 lm); F1,705 = 74.302 (4–6 lm);
F1,372 = 100.001 (6–8 lm); F1,143 = 30.694 (8–10 lm); p < 0.001] in
all categories except 0–2 lm class of axons (F1,270 = 3.256; p = 0.072)
(Fig. 2E,F). Large-diameter (8–10 lm) axons g-ratio (motor-related)
was different between old (p < 0.001), but not adult, Tau+/+ and
Tau/. This g-ratio variation in large-diameter axons between Tau/
and Tau+/+ of the two ages is also depicted in the regression lines of g-
ratio growth in Tau/ (grey) and Tau+/+ (black) of adult and old
animals (inserted micrographs in Fig. 2E and 2F, respectively), where the
regression lines for adult, but not old, animals are converging at the
large-diameter axons indicating no difference between g-ratios of
Tau/ and Tau+/+ of this fiber category. The above ultrastructural
hypomyelination findings in sciatic nerves of Tau/ animals were
further confirmed by reduced protein levels of myelin basic protein (MBP)
(Fig. 2G).
Next, we monitored in vivo compound muscle (M) and reflex (H)
nerve action potentials in hindpaw of anesthetized animals (Fig. 3A–E).
As shown in Fig. 3B,C, there were no differences between amplitudes or
total response area of direct muscle action potentials—M-wave—
between Tau+/+ and Tau/ on both ages. Regarding the H-waves
which represent the reflex response that travels via the sciatic nerve
(sensitive to lidocaine local sciatic application; Fig. 3A), two-way ANOVA
showed an Aging main effect [F1,17 = 6.701, p = 0.018] on the
amplitude but no changes between Tau/ and Tau+/+ animals of
both ages (Fig. 3D). Moreover, assessment of the total response area
exhibited a significant reduction in old Tau/ animals when compared
to old Tau+/+ (p = 0.02; Fig. 3E); note that this difference was not
found in adult animals (p = 0.64). We also found a Genotype x Aging
interaction effect [F1,17 = 9.40, p = 0.007] as well as an aging main
effect [F1,17 = 49.78, p < 0.0001]. Based on the morphological alter-
ations of sciatic nerve described above, we next monitored nerve
function by ex vivo recordings in isolated sciatic nerves, as previously
described (Pinto et al., 2008) (Fig. 3F). Two-way ANOVA revealed no
differences in conduction velocity of A-fibers among both ages and
genotypes (Fig. 3G). However, assessment of the total response area
revealed a significant Genotype x Aging interaction [F1,31 = 6.715,
P = 0.0144]. Particularly, we observed that sciatic nerves from old
Tau/ animals presented a decreased conduction capacity when
compared with old Tau+/+ animals (P = 0.03) (Fig. 3H), indicating
diminished overall response ability for old Tau/ sciatic nerves; the
same was not valid for adult animals again providing further evidence
about the age-dependent impact of Tau loss on sciatic nerve.
Discussion
Tau is a soluble cytoskeletal protein that is expressed mainly in neurons
and in glial cells, of both CNS and PNS; it is implicated in various cellular
processes such as microtubule stabilization, axonal maintenance, and
transport. Tau malfunction is also causally related to AD pathology in
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Fig. 1 Impaired motor behavior of old Tau/ animals. Behavioral screening of motor functions revealed that lack of Tau protein led to an age-dependent motor
dysfunction. (A) Rotarod test showed that old, but not adult, Tau/ animals exhibited reduced latency to fall when compared with Tau+/+ reflecting motor impairment. (B)
Total distance travelled in open field was reduced in old Tau/ when compared with old Tau+/+ and adult Tau/ animals indicating reduced locomotor activity. (C) Wire-
hanging test assessments showed that old Tau/ animals differed from old Tau+/+ and adult Tau/ presenting significantly less hanging time. D-E) Hindlimb tonus
resistance (D) and forelimb strength (E) were severely reduced in old Tau/ animals compared with old and adult Tau+/+. (F) No changes in hindlimb clasping score
between animals of both ages and genotypes. (G–J) Footprinting-based gait analysis showed that, in contrast to adult animals, old Tau/ present reduced stride length
when compared to old Tau+/+ (G), while no other changes were found between animals of two genotypes. (K) Representative image of animal footprints which were used
to calculate the different gait parameters, for example, stride length *(G), forepaw base (H), hindpaw base (I), and forepaw/hindpaw overlap (J). All numeric data are
presented as mean  SEM; *p < 0.05; **p < 0.01; ***p < 0.001.
Tau/ motor and sciatic nerve deficits, S. Lopes et al.210
ª 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
where aberrant, hyperphosphorylated and/or aggregated, forms of Tau
are found in the CNS and in the PNS (Holzer et al., 1999). Accordingly,
recent evidence suggests Tau protein as the final executor of AD neuronal
dysfunction (Roberson et al., 2007; Ittner & Gotz, 2011) and, therefore,
anti-Tau therapies emerged as potential strategies against AD (Frost et al.,
2015); however, their safety or potential risks have not been defined yet.
Evidence from different Tau/ models suggests that absence of Tau
is well tolerated by young/adult animals probably due to the occurrence
of compensatory mechanisms (e.g., increase in MAP1A, another
microtubule-associated protein) (Dawson et al., 2001; Ma et al.,
2014). In contrast, aged Tau/ seem to exhibit mild motor deficits
albeit the effect of Tau depletion on motor performance by aging
remains controversial and unclear. A study from Ikegami et al. (2000)
reports signs of muscle weakness (tested by wire-hanging) and reduced
balance coordination in 2-month-old Tau/, but Morris et al. (2011)
showed normal motor function of young (3–5 months old) and adult
animals of another Tau/ mouse line in a variety of motor tests (B6
background; Dawson et al. (2001)) in agreement with this study
Fig. 2 Ultrastructural analysis of Tau/ and Tau+/+ sciatic nerves. (A, B) Representative light microscopy photograph of ppd staining of sciatic nerve (A) and quantification
of fibers density (B) showing an age-dependent reduction in both Tau/ and Tau+/+. (C) TEM analysis images of sciatic nerve showing normal (i) and degenerating (ii, iii)
myelinated fibers with obvious myelin anomalies while severely damaged axons (iv) were very rarely found in all groups. (D) Old Tau/ animals present a significant increase
in percentage of degenerating fibers when compared with old Tau+/+ animals. (E, F) Detailed evaluation of g-ratio [axon diameter/(axon diameter + myelin thickness)] per
axon diameter category in adult (E) and old (F) animals. There is an age-dependent g-ratio reduction (hypomyelination) in Tau/ vs. Tau+/+ starting from axons of small and
middle diameter (nonmotor related) in adult animals (E) and extending to large-diameter (8–10 lm), motor-related axons in old Tau/ (F). Specifically, compared to adult
Tau+/+ ones, adult Tau/ animals exhibited increased g-ratio in all fiber categories except that of 8–10 lm, while in old Tau/, this category g-ratio was also affected (E).
Insets represent regression lines of g-ratio growth in Tau/ (red) and Tau+/+ (black) of adult (D) and old (E) animals where the regression lines for adult, but not old,
animals are converging at the large-diameter axons, indicating no difference between g-ratio of Tau/ and Tau+/+ of this fiber category. G-H) Western blot analysis
showed reduced myelin basic protein (MBP) levels in Tau/ sciatic nerves (G) in line with the g-ratio analysis as well as absence of the characteristic high molecular weight
Tau (HMW-Tau; 110 kDa) (H) in sciatic nerves of Tau/ animals. Data are presented as mean  SEM; *p < 0.05; **p < 0.01; ***p < 0.001.
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findings. Moreover, the same team found mild motor deficits in middle-
aged (12–15 months old) Tau/ animals using rotarod and pole tests
but, unexpectedly, these motor deficits were not clearly evident in old
(21–22 months old) Tau/ (Morris et al., 2013). In contrast, we
observed clear motor deficits in old (17–22 months old) Tau/ using
the rotarod, wire-hanging, and open-field tests and these deficits were
not correlated with body weight. In addition, our study offers additional
evidence of motor dysfunction showing that, in line with our wire-
hanging data, old Tau/ animals also exhibit reduced forelimb (grip)
strength and diminished hindlimb tonus resistance compared to old wild-
types but they exhibit no deficits in gross aspects of motor function/
balance as assessed by hindlimb clasping tests (see Fig. 1) and negative
geotaxis (data not shown). Interestingly, reduced motor strength and
coordination was also shown in 13- to 17-month-old animals lacking 4R-
Tau, suggesting the potential role of 4RTau in the age-dependent
development of motor deficits (Gumucio et al., 2013).
The mechanisms underlying the impaired motor behavior in the
absence of Tau in aged individuals are not entirely understood with
contradictory findings being reported. Lei et al. (2012), for instance,
reported an age-related loss of SN dopaminergic neurons in middle-aged
Tau/ animals. In contrast, a recent study on the same Tau/ line
failed to observe any major dopaminergic loss in different CNS motor
components of old Tau/ mice (Morris et al., 2013). While both
studies showed motor deficits, Lei et al. (2012) showed nigrostriatal loss
Fig. 3 Tau ablation results in age-dependent sciatic nerve malfunction. (A) Representative traces of in vivo electrophysiological recordings of compound muscle (M) and
reflex (H) nerve action potentials (upper panel); lidocaine injection locally at the sciatic resulted in loss of H-wave without affecting the muscle M-wave (lower panel). (B, C)
No differences in both amplitude (B) and total response area (C) of M-waves between animals of both genotypes and ages. (D) Age-dependent increase in amplitude of H-
waves (Aging main effect, see also results), but no difference between Tau/ and Tau+/+ animals. (E) Old Tau/ exhibited significantly reduced total response area
compared to old Tau+/+ animals, while this difference was not found in adult animals. In addition, there was an age-dependent difference in both Tau+/+ and Tau/
animals. (F) Representative traces of current-clamp recordings of sciatic nerve compound action potentials in adult and old Tau+/+ and Tau/ mice. Sciatic nerves received
repeated stimuli with increasing amplitudes pulses until saturation. Stimulation artifacts were truncated (conduction distance: adult Tau+/+: 5.5 mm; adult Tau/:
9.6 mm; old Tau+/+: 8.0 mm; old Tau/: 9.8 mm); traces are averages of five consecutive recordings. (G, H) While no differences in conduction velocity (m s1) between
Tau+/+ and Tau/ were found (G), total area under the curve (mV.ms) of old Tau/ was significantly reduced compared to old Tau+/+ animals indicating sciatic nerve
malfunction (H). Data presented as mean  SEM; p < 0.05.
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in middle-aged Tau/ mice of C57BL/6/SV129 background, while our
study and the study of Morris et al. (2013) found no nigrostriatal
neuronal loss in old mice with C57BL/6 background (data not shown).
Furthermore, in a later study, Lei et al. (2014) showed that motor deficits
of old Tau/ animals do not depend on background or have a sex-
dependent profile. In line with it, despite the fact that our study has used
male animals and Morris study (2013) used a mixed (male and female)
cohort, both studies exhibit motor deficits providing further support of
no gender influence in the old Tau/ motor deficits.
While a number of CNS areas have been implicated in the emergence
of AD-associated motor deficits, little attention has been devoted to PNS
primary efferents. Previous evidence suggests that the sciatic nerves of
patients with AD, but not of age-matched healthy individuals, exhibit
reduced Tau levels (Holzer et al., 1999). In our study, we demonstrate
that chronic loss of Tau protein results in sciatic nerve morphofunctional
deficits which includes increased percentage of degenerating fibers,
hypomyelination of large-diameter, motor-related fibers, and diminished
conduction properties in old, but not young, Tau/ sciatic nerve. While
other mechanisms cannot be excluded, the aforementioned sciatic nerve
deficits may critically contribute to motor deficits found in old Tau/ as
fine-tuning of myelin sheath thickness and formation is important for
maintenance and proper function of motor fibers. In addition, while no
amplitude differences in muscle action potentials of Tau/ were
found, further studies are needed to clarify the impact of loss of Tau on
neuromuscular junction by aging as Tau-related pathology in motor
neurons has been shown to have neuromuscular junction malfunction
and motor deficits in AD Tg models (Zhang et al., 2005; Ubhi et al.,
2007).
Despite the fact that axon–Schwann cell interactions are critical for
nerve function and maintenance, the underlying mechanisms of
maintaining normal nerve and Schwann cell structure and function
remain poorly understood. Tau is expressed in both CNS and PNS, but
the low molecular weight isoforms of Tau protein that are expressed in
adult CNS differ from high molecular weight (HMW) Tau isoforms mainly
found in PNS (e.g., sciatic nerves) but also in optical nerves (Sato-
Yoshitake et al., 1989; Georgieff et al., 1991; Nothias et al., 1995). The
expression of HMW tau isoforms may confer increased stabilization and
spacing of microtubules (Frappier et al., 1994; Boyne et al., 1995) but
yet, our knowledge about Tau function in PNS is very limited. While
previous cell-based evidence suggests the involvement of Tau in
myelination of oligodendrocytes, the current study provides ultrastruc-
tural and molecular support of Tau role in myelination of PNS. Neuronal
axon–Schwann cell interaction(s) are essential for myelination, and
myelin maintenance is a dynamic process tightly controlled by axon-
dependent transcription factors such as Krox20 and Oct6 (Murphy et al.,
1996; Decker et al., 2006). In line with previous studies demonstrating
an absence of axonal deficits in neurons of Tau/ animals (Yuan et al.,
2008; Vossel et al., 2010), there were no differences in mRNA levels of
transcription factors that critically regulate myelination process and/or
maintenance, for example, Krox20 and Oct6 (data not shown),
suggesting no gross changes in myelin gene regulation of Tau/
Schwann cells. Furthermore, supporting the involvement of Tau and
other cytoskeletal elements in myelination process, previous evidence
suggests that Tau strongly colocalizes with MBP in distal tips of
oligodendrocytes (LoPresti et al., 1995; Muller et al., 1997), suggesting
that transportation and/or local MBP translation may require microtubule
cytoskeleton and might be controlled by Tau–Fyn interaction (Klein
et al., 2002). As recent evidence suggests that Tau is responsible to
locate Fyn in spines and Fyn has a well-described role in myelination
of both CNS and PNS (Kramer-Albers & White, 2011), the above
Tau–Fyn–MBP complex could be disrupted in the absence of Tau protein,
affecting myelination signaling and process. Indeed, Taiep myelin-
mutant animals exhibit irregular microtubule polarity and display
abnormal Tau accumulation and intracellular accumulation of myelin
proteins in oligodendrocytes (Song et al., 2001), while PNS myelin-
deficient mice also exhibited reduction in Tau and other cytoskeletal
protein in their sciatic nerves (Kirkpatrick & Brady, 1994). The above
findings suggest that the absence of Tau may impact on Schwann cells’
myelination process/signaling, opening a novel window for further
research on role of Tau protein in PNS. Furthermore, in light of the
suggested therapeutic potential of Tau reduction against AD, a better
understanding of the impact of Tau ablation in both CNS and PNS is of
great importance. Our findings highlight the morphological and func-
tional implication of peripheral nerves induced by Tau loss in the
precipitation of motor deficits with increasing aging and should be taken
into account in the development of future AD therapies.
Experimental procedures
Animals
In this study, 4- to 6- and 17- to 22-month-old male Tau+/+ and Tau/
(Dawson et al. (2001); C57BL/6 background) were used. Mice were
housed 4–5 animals per cage under standard environmental conditions
with ad libitum access to food and water. All experimental procedures
were approved by the local ethical committee and national authority for
animal experimentation and were in accordance with the guidelines for
the care and handling of laboratory animals, as described in the Directive
2010/63/EU.
Behavioral tests
Rotarod, wire-hanging, and open-field tests were performed. Animals
were acclimated to the testing conditions for 60 min before testing. For
rotarod test (TSE systems, Bad Homburg, Germany), mice were first
trained a constant speed (15 rpm) for 3 days (4 trials per day; 60-s max
trial time; 10-min resting interval among trials). At fourth day, mice
(N = 9–11 for each genotype) were tested on an accelerating rod (4–
40 rpm, 5 min; four trials); in this case, latency to fall was automatically
recorded. For wire-hanging test, animals were placed on a standard wire
cage grid, which was then inverted and at 30 cm height from the table
surface. The latency to animal fall was manually recorded (two trials;
maximum time of each trial: 120 s). The open field was performed in a
square arena (43.2 9 43.2 cm) surrounded by tall perspex walls (Med
Associates Inc., St. Albans, VT, USA). Mice were placed in the center of
the arena allowed to explore during 10 min. Infrared beams were used
to automatically register animals’ movements. We next monitored
forelimb strength, hindlimb tonus, hindlimb clasping, negative geotaxis,
and gait analysis as previously described (Silva-Fernandes et al., 2014).
For all tests, scoring was carried out manually by an experimenter blind
to the genotype and age of the animals. Briefly, for the assessment of
forelimb (grid) strength, animal was positioned on a metal grid and
gently pulled off by its tail (hindlimbs were suspended slightly above the
grid), while the animal was gripping a wire using its forelimbs. A scale of
four different scores was used by the experimenter evaluating forelimb
strength of the animal: 0 (no strength), 1 (light/semi-effective), 2
(moderate/effective), and 3 (active/effective). Hindlimb tonus was tested
by pressing animals’ hindlimb paw (by experimenter index finger)
evaluating muscular resistance and classifying into four different
categories: 0 (no resistance), 1 (slight resistance), 2 (moderate resis-
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tance), and 3 (pronounced resistance). Assessment of hindlimb clasping
was performed suspending animals by the tail during 30 s. The
hindlimbs were observed, and each mouse was given a score for each
trial. Hindlimb clasping was rated based on two classes: 1 (hindlimb
splayed outward and away of the abdomen) and 2 (hindlimbs retracted
inward, toward the abdomen for at least more than 50% of the testing
time). Next, we also performed gait analysis based on footprinting.
Briefly, the hind- and forepaws of the mice were coated with black and
red nontoxic paints, respectively. The animals were allowed to walk
along 100-cm-long 9 4.2-cm-width 9 10-cm-height corridor, with
ordinary white paper on the floor of the runway for each run. Each
animal was tested to achieve one valid trial. The footprint patterns were
analyzed manually for four step parameters (measured in cm): the front-
and hind-base width, the footstep uniformity, and the stride length. For
the analysis of each step parameter, three values were used based on
three consecutive steps.
Sciatic nerve ultrastructure analysis
Under deep anesthesia [ketamine hydrochloride (75 mg kg1) and
medetomidine (1 mg kg1)], sciatic nerves were collected and immedi-
ately fixed in 4% glutaraldehyde (in 0.1 M sodium cacodylate buffer, pH
7.4) for 7 days and room temperature and then postfixed in 1% OsO4,
dehydrated. Finally, the tissue was embedded in epon resin (Electron
Microscopy Sciences) and sectioned according to the objective (see
below). One-micrometer transverse sections covering the complete
cross-sectional nerve area were stained with 1% p-phenylene diamine
and mounted on Entellan (Merk). Light microscope (Olympus DP70,
Hamburg, Germany) images were then mounted on Photoshop and
used for manual calculation of number and density of myelinated fibers
per transverse section (4–5 animals per group). For the assessment of
degenerating fibers, 16 nonoverlapping TEM photographs (30009) of
counterstained ultrathin sections (60 nm) were used (obtained by JEM-
1400 TEM). The same TEM images were also used for g-ratio [axon
diameter/(axon diameter + myelin thickness)] calculation; more than one
hundred fibers were measured per animal. Morphometric analysis was
performed by an experimenter blind to the samples provenience.
Ex vivo measurement of compound action potentials
Acutely isolated sciatic nerves from each group (6–8 animals per group)
were used for the assessment of A- and C-fibers conduction velocity and
compound action potentials as previously described (Pinto et al., 2008).
Briefly, sciatic nerves were dissected and cleaned from the connective
tissue sheath in artificial cerebrospinal fluid. Compound action potentials
recordings were made with a Multiclamp 700B amplifier in CC mode and
digitized with the Digidata 1440a digitizer using PCLAMP 10 software
(Axon Instruments, Sunnyvale, CA, USA). Signalswere low-pass-filtered at
an effective corner frequency of 16 KHz and sampled at 50 KHz. Fibers
were stimulated at 60 ls, and conduction velocities were calculated for
the first compound action potentials peak; total areas were calculated
using CLAMPFIT software (Axon Instruments). Electrophysiological
recordings and analyses were performed by an experimenter blind to
the provenience of the tissue.
In vivo electrophysiological measurements
The in vivo approach allowed the acquisition of electroneuromyographic
recordings in a noninvasive manner as described previously (Petit et al.,
2014). Briefly, 5–6 mice per group were anesthetized with a mixture of
ketamine (75 mg kg1; Imalgene, Merial, France) and medetomidine
(1 mg kg1; Dormitor, Pfizer, New York, NY, USA) i.p. administered.
Temperature was monitored and maintained at 37 °C by a homeother-
mic blanket (Stoelting, Dublin, Ireland). A concentric bipolar platinum/
iridium–stainless steel stimulation electrode (WPI, Worcester, MA, USA)
was used to deliver 0.1 ms square pulses to the tibial nerve at the ankle,
through a small skin incision. The ground stainless steel electrode was
inserted at the base of the tail. Compound muscle action potentials
(CMAPs) were recorded from the plantar muscles of both hindpaws
individually through stainless steel electrodes (diameter: 0.28 mm;
Science Products, Hofheim, Germany) inserted in the plantar muscle
and subcutaneously in the third toe. Signals evoked by 1-mA electrical
stimulation at 0.1 Hz were amplified, filtered (3–3000 Hz, LP511 Grass
Amplifier, Astro-Med, Rodgau, Germany), acquired (Micro 1401 mkII,
CED, Cambridge, UK), and recorded using SIGNAL Software (CED). This
setup allowed the recording of CMAPs containing (1) stimulus artifact;
(2) early nerve action potential; (3) direct muscle response (M-wave); and
(4) monosynaptic reflex response (H-wave; Fig. 3A, upper panel); the
latest was specifically abolished by lidocaine (2%; B Brown, Germany)
injected in the vicinity of the sciatic nerve in the mouse thigh in a control
experiment (Fig. 3A, lower panel). Averages of five consecutive
responses were analyzed to measure amplitudes and area under curve
of M- and H-waves to the baseline. The values obtained for each paw
were averaged per animal.
Western blot analysis
Tau/ and Tau+/+ sciatic nerves were homogenized [10 mM HEPES pH
7.9, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 10% glycerol, 1% NP-40,
Complete Protease Inhibitor (Roche, Mannheim, Germany) and Phos-
phatase Inhibitor Cocktails II and III (Sigma, St Louis, MO, USA)]. After
sonication and centrifugation (15 000 g; 10 min; 4 °C), protein contents
were estimated by Bradford assay and lysates were electrophoresed on
10% acrylamide gels, and transferred onto nitrocellulose membranes
(BIORAD Turbo,Munich, Germany). For detectingMBP levels, membranes
were blocked in Tris-buffered saline containing 5% nonfat milk in TBS-T
before incubation with antibodies against MBP (Serotec, Oxford, UK;
1:500), Tau (abcam, Cambridge, UK; 1:1000), and actin (DSHB, University
of Iowa, IA, USA; 1:2000). Antigens were revealed by enhanced
chemiluminescence (BIORAD) after incubation with appropriate horse-
radish peroxidase–immunoglobulin G conjugates (BIORAD). Blots were
scanned and quantified using TINA 3.0 bioimaging software (Raytest,
Straubenhardt, Germany). All values were normalized against actin.
Statistical analysis
Unless otherwise specified, two-way ANOVA was used having genotype
(Tau+/+ vs. Tau/) and aging (adult vs. old) as factors and followed by
Tukey post hoc analysis (SPSS, Aspire Software, Armonk, NY, USA).
Differences were considered to be significant if p < 0.05.
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